BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23925934)

  • 21. Plasmid DNAs encoding insulin and glutamic acid decarboxylase 65 have distinct effects on the progression of autoimmune diabetes in nonobese diabetic mice.
    Weaver DJ; Liu B; Tisch R
    J Immunol; 2001 Jul; 167(1):586-92. PubMed ID: 11418698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The recombinant fusion protein of cholera toxin B and neutrophil-activating protein expressed on Bacillus subtilis spore surface suppresses allergic inflammation in mice.
    Dong H; Huang Y; Yao S; Liang B; Long Y; Xie Y; Mai J; Gong S; Zhou Z
    Appl Microbiol Biotechnol; 2017 Jul; 101(14):5819-5829. PubMed ID: 28608279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bacterial and plant enterotoxin B subunit-autoantigen fusion proteins suppress diabetes insulitis.
    Carter JE; Yu J; Choi NW; Hough J; Henderson D; He D; Langridge WH
    Mol Biotechnol; 2006 Jan; 32(1):1-15. PubMed ID: 16382177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered B:9-23 insulin, when administered intranasally with cholera toxin adjuvant, suppresses the expression of insulin autoantibodies and prevents diabetes.
    Kobayashi M; Abiru N; Arakawa T; Fukushima K; Zhou H; Kawasaki E; Yamasaki H; Liu E; Miao D; Wong FS; Eisenbarth GS; Eguchi K
    J Immunol; 2007 Aug; 179(4):2082-8. PubMed ID: 17675466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nasal administration of CTB-insulin induces active tolerance against autoimmune diabetes in non-obese diabetic (NOD) mice.
    Aspord C; Thivolet C
    Clin Exp Immunol; 2002 Nov; 130(2):204-11. PubMed ID: 12390307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic alteration of insulin-dependent diabetes mellitus progression by T cell tolerance to glutamic acid decarboxylase 65 peptides in vitro and in vivo.
    Wilson SS; White TC; DeLuca D
    J Immunol; 2001 Jul; 167(1):569-77. PubMed ID: 11418696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cloning, expression, purification and characterization of the cholera toxin B subunit and triple glutamic acid decarboxylase epitopes fusion protein in Escherichia coli.
    Gong Z; Long X; Pan L; Le Y; Liu Q; Wang S; Guo J; Xiao B; Zhou M; Mei D
    Protein Expr Purif; 2009 Aug; 66(2):191-7. PubMed ID: 19364533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of glutamic acid decarboxylase-activated T cells with I-Ag7 tetramers.
    Liu CP; Jiang K; Wu CH; Lee WH; Lin WJ
    Proc Natl Acad Sci U S A; 2000 Dec; 97(26):14596-601. PubMed ID: 11106373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MHC class I-restricted determinants on the glutamic acid decarboxylase 65 molecule induce spontaneous CTL activity.
    Quinn A; McInerney MF; Sercarz EE
    J Immunol; 2001 Aug; 167(3):1748-57. PubMed ID: 11466400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection and characterization of T cells specific for BDC2.5 T cell-stimulating peptides.
    You S; Chen C; Lee WH; Wu CH; Judkowski V; Pinilla C; Wilson DB; Liu CP
    J Immunol; 2003 Apr; 170(8):4011-20. PubMed ID: 12682229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulatory and effector CD4 T cells in nonobese diabetic mice recognize overlapping determinants on glutamic acid decarboxylase and use distinct V beta genes.
    Quinn A; McInerney B; Reich EP; Kim O; Jensen KP; Sercarz EE
    J Immunol; 2001 Mar; 166(5):2982-91. PubMed ID: 11207247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mucosally induced immunological tolerance, regulatory T cells and the adjuvant effect by cholera toxin B subunit.
    Sun JB; Czerkinsky C; Holmgren J
    Scand J Immunol; 2010 Jan; 71(1):1-11. PubMed ID: 20017804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glutamic acid decarboxylase T lymphocyte responses associated with susceptibility or resistance to type I diabetes: analysis in disease discordant human twins, non-obese diabetic mice and HLA-DQ transgenic mice.
    Boyton RJ; Lohmann T; Londei M; Kalbacher H; Halder T; Frater AJ; Douek DC; Leslie DG; Flavell RA; Altmann DM
    Int Immunol; 1998 Dec; 10(12):1765-76. PubMed ID: 9885897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Production of a recombinant cholera toxin B subunit-insulin B chain peptide hybrid protein by Brevibacillus choshinensis expression system as a nasal vaccine against autoimmune diabetes.
    Yuki Y; Hara-Yakoyama C; Guadiz AA; Udaka S; Kiyono H; Chatterjee S
    Biotechnol Bioeng; 2005 Dec; 92(7):803-9. PubMed ID: 16142801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Active tolerance induction and prevention of autoimmune diabetes by immunogene therapy using recombinant adenoassociated virus expressing glutamic acid decarboxylase 65 peptide GAD(500-585).
    Han G; Li Y; Wang J; Wang R; Chen G; Song L; Xu R; Yu M; Wu X; Qian J; Shen B
    J Immunol; 2005 Apr; 174(8):4516-24. PubMed ID: 15814672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppression of ongoing T cell-mediated autoimmunity by peptide-MHC class II dimer vaccination.
    Li L; Yi Z; Wang B; Tisch R
    J Immunol; 2009 Oct; 183(7):4809-16. PubMed ID: 19752238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of oral tolerance to prevent diabetes with transgenic plants requires glutamic acid decarboxylase (GAD) and IL-4.
    Ma S; Huang Y; Yin Z; Menassa R; Brandle JE; Jevnikar AM
    Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5680-5. PubMed ID: 15056761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced immunological tolerance against allograft rejection by oral administration of allogeneic antigen linked to cholera toxin B subunit.
    Sun JB; Li BL; Czerkinsky C; Holmgren J
    Clin Immunol; 2000 Nov; 97(2):130-9. PubMed ID: 11027453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD4(+) T cells from glutamic acid decarboxylase (GAD)65-specific T cell receptor transgenic mice are not diabetogenic and can delay diabetes transfer.
    Tarbell KV; Lee M; Ranheim E; Chao CC; Sanna M; Kim SK; Dickie P; Teyton L; Davis M; McDevitt H
    J Exp Med; 2002 Aug; 196(4):481-92. PubMed ID: 12186840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protection of NOD mice from type 1 diabetes after oral inoculation with vaccinia viruses expressing adjuvanted islet autoantigens.
    Denes B; Krausova V; Fodor N; Timiryasova T; Henderson D; Hough J; Yu J; Fodor I; Langridge WH
    J Immunother; 2005; 28(5):438-48. PubMed ID: 16113600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.